The conversation surrounding healthcare reform has intensified in recent years, revealing deep divides in how we view ...

Here’s why Restaurant Brands (TSX:QSR) remains a magnificent Canadian stock worth buying right now.

Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...

Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...